V. Bhardwaj

3.5k total citations · 1 hit paper
20 papers, 2.9k citations indexed

About

V. Bhardwaj is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, V. Bhardwaj has authored 20 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 6 papers in Biomaterials. Recurrent topics in V. Bhardwaj's work include Advanced Drug Delivery Systems (12 papers), Drug Solubulity and Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (4 papers). V. Bhardwaj is often cited by papers focused on Advanced Drug Delivery Systems (12 papers), Drug Solubulity and Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (4 papers). V. Bhardwaj collaborates with scholars based in India, Germany and United Kingdom. V. Bhardwaj's co-authors include M. N. V. Ravi Kumar, D. D. Ankola, Gaurav Mittal, S. Hariharan, Indu Bala, Venkat Ratnam Devadasu, Kulbhushan Tikoo, Johannes Sitterberg, Udo Bakowsky and Bhoomi Viswanad and has published in prestigious journals such as Chemical Reviews, Biomaterials and Journal of Controlled Release.

In The Last Decade

V. Bhardwaj

20 papers receiving 2.7k citations

Hit Papers

Role of antioxidants in prophylaxis and therapy: A pharma... 2006 2026 2012 2019 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective
    2006 671 citations D. D. Ankola, V. Bhardwaj et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Bhardwaj India 17 969 931 615 367 347 20 2.9k
Sonia Trombino Italy 34 782 0.8× 666 0.7× 770 1.3× 278 0.8× 415 1.2× 117 3.2k
Sami Nazzal United States 31 1.4k 1.5× 522 0.6× 834 1.4× 198 0.5× 323 0.9× 96 3.0k
Xiuhua Zhao China 31 526 0.5× 596 0.6× 603 1.0× 270 0.7× 696 2.0× 142 3.1k
Jiangnan Yu China 39 827 0.9× 730 0.8× 1.5k 2.5× 234 0.6× 525 1.5× 171 4.3k
Roberta Cassano Italy 31 694 0.7× 611 0.7× 561 0.9× 116 0.3× 409 1.2× 110 2.7k
Ximing Xu China 41 913 0.9× 970 1.0× 1.8k 2.8× 248 0.7× 666 1.9× 160 4.6k
Ruckmani Kandasamy India 37 726 0.7× 677 0.7× 887 1.4× 136 0.4× 476 1.4× 150 3.7k
Shubhini A. Saraf India 27 737 0.8× 448 0.5× 734 1.2× 122 0.3× 189 0.5× 163 2.9k
Deep Pooja India 31 480 0.5× 959 1.0× 887 1.4× 128 0.3× 618 1.8× 70 2.6k
Shufang Nie China 27 1.5k 1.6× 508 0.5× 661 1.1× 208 0.6× 252 0.7× 58 2.9k

Countries citing papers authored by V. Bhardwaj

Since Specialization
Citations

This map shows the geographic impact of V. Bhardwaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Bhardwaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Bhardwaj more than expected).

Fields of papers citing papers by V. Bhardwaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Bhardwaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Bhardwaj. The network helps show where V. Bhardwaj may publish in the future.

Co-authorship network of co-authors of V. Bhardwaj

This figure shows the co-authorship network connecting the top 25 collaborators of V. Bhardwaj. A scholar is included among the top collaborators of V. Bhardwaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Bhardwaj. V. Bhardwaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhardwaj, V., Niraj S. Trasi, Dmitry Zemlyanov, & Lynne S. Taylor. (2018). Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion. International Journal of Pharmaceutics. 540(1-2). 106–119. 48 indexed citations
2.
3.
Devadasu, Venkat Ratnam, V. Bhardwaj, & M. N. V. Ravi Kumar. (2012). Can Controversial Nanotechnology Promise Drug Delivery?. Chemical Reviews. 113(3). 1686–1735. 184 indexed citations
4.
Bhardwaj, V., Jane A. Plumb, J Cassidy, & M. N. V. Ravi Kumar. (2010). Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer. Cancer Nanotechnology. 1(1-6). 29–34. 9 indexed citations
5.
6.
Panchagnula, Ramesh & V. Bhardwaj. (2008). Effect of Amorphous Content on Dissolution Characteristics of Rifampicin. Drug Development and Industrial Pharmacy. 34(6). 642–649. 16 indexed citations
7.
8.
Bhatt, Devendra Kumar, et al.. (2007). PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral®. Journal of Controlled Release. 119(2). 197–206. 160 indexed citations
9.
Ankola, D. D., Bhoomi Viswanad, V. Bhardwaj, Poduri Ramarao, & M. N. V. Ravi Kumar. (2007). Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?. European Journal of Pharmaceutics and Biopharmaceutics. 67(2). 361–369. 91 indexed citations
10.
Viswanad, Bhoomi, et al.. (2007). Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials. 28(11). 2051–2060. 93 indexed citations
11.
12.
13.
Bhardwaj, V., et al.. (2006). Disease, destination, dose and delivery aspects of ciclosporin: the state of the art. Drug Discovery Today. 11(17-18). 846–854. 58 indexed citations
14.
Ankola, D. D., et al.. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. Journal of Controlled Release. 113(3). 189–207. 671 indexed citations breakdown →
15.
Bala, Indu, V. Bhardwaj, S. Hariharan, et al.. (2006). Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration. Journal of drug targeting. 14(1). 27–34. 81 indexed citations
16.
Bhardwaj, V., et al.. (2006). Simultaneous analysis of ellagic acid and coenzyme Q10 by derivative spectroscopy and HPLC. Talanta. 70(2). 387–391. 23 indexed citations
17.
Bala, Indu, V. Bhardwaj, S. Hariharan, & M. N. V. Ravi Kumar. (2005). Analytical methods for assay of ellagic acid and its solubility studies. Journal of Pharmaceutical and Biomedical Analysis. 40(1). 206–210. 214 indexed citations
18.
Hariharan, S., V. Bhardwaj, Indu Bala, et al.. (2005). Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy. Pharmaceutical Research. 23(1). 184–195. 217 indexed citations
19.
Bala, Indu, V. Bhardwaj, S. Hariharan, et al.. (2005). Design of biodegradable nanoparticles: a novel approach to encapsulating poorly soluble phytochemical ellagic acid. Nanotechnology. 16(12). 2819–2822. 64 indexed citations
20.
Bhardwaj, V., S. Hariharan, Indu Bala, et al.. (2005). Pharmaceutical Aspects of Polymeric Nanoparticles for Oral Drug Delivery. Journal of Biomedical Nanotechnology. 1(3). 235–258. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Trombino Breakdown of academic impact, for papers by Sami Nazzal Breakdown of academic impact, for papers by Xiuhua Zhao Breakdown of academic impact, for papers by Jiangnan Yu Breakdown of academic impact, for papers by Roberta Cassano Breakdown of academic impact, for papers by Ximing Xu Breakdown of academic impact, for papers by Ruckmani Kandasamy Breakdown of academic impact, for papers by Shubhini A. Saraf Breakdown of academic impact, for papers by Deep Pooja Breakdown of academic impact, for papers by Shufang Nie
Rankless by CCL
2026